Shaanxi Meibang Pharmaceutical (605033)

Search documents
美邦股份(605033) - 陕西美邦药业集团股份有限公司关于召开2025年半年度业绩说明会的公告
2025-09-12 08:15
证券代码:605033 证券简称:美邦股份 公告编号:2025-048 陕西美邦药业集团股份有限公司 关于召开2025年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 陕西美邦药业集团股份有限公司(以下简称"公司")已于 2025 年 8 月 27 日在上海证券交易所网站(www.sse.com.cn)披露了《陕西美邦药业集团股份有 限公司 2025 年半年度报告》及《陕西美邦药业集团股份有限公司 2025 年半年度 会议召开时间:2025 年 09 月 19 日(星期五)15:00-16:00 会议召开地点:价值在线(www.ir-online.cn) 会议召开方式:网络互动方式 会 议 问 题 征 集 : 投 资 者 可 于 2025 年 09 月 19 日 前 访 问 网 址 https://eseb.cn/1rtAj5lSNmE 或使用微信扫描下方小程序码进行会前提 问,公司将通过本次业绩说明会,在信息披露允许范围内就投资者普遍 关注的问题进行回答。 报告摘要》。为便于广大投资者 ...
美邦股份成立出发点作物方案公司
Zheng Quan Shi Bao Wang· 2025-09-11 07:30
人民财讯9月11日电,企查查APP显示,近日,陕西出发点作物方案有限公司成立,法定代表人为黄兆 中,经营范围包含:生物有机肥料研发;复合微生物肥料研发;生物农药技术研发等。企查查股权穿透 显示,该公司由美邦股份(605033)全资持股。 ...
美邦股份今日大宗交易折价成交14.43万股,成交额299.86万元
Xin Lang Cai Jing· 2025-09-05 09:38
Summary of Key Points Core Viewpoint - On September 5, Meibang Co., Ltd. executed a block trade of 144,300 shares, amounting to 2.9986 million yuan, which represented 2.61% of the total trading volume for the day. The transaction price was 20.78 yuan, reflecting a discount of 12.39% compared to the market closing price of 23.72 yuan [1]. Group 1 - The block trade involved a total of 144,300 shares [1]. - The total transaction amount was 2.9986 million yuan [1]. - The transaction price was set at 20.78 yuan per share [1]. Group 2 - The block trade accounted for 2.61% of the total trading volume on that day [1]. - The discount of 12.39% was calculated based on the market closing price of 23.72 yuan [1].
农化制品板块9月2日跌2.2%,司尔特领跌,主力资金净流出9.73亿元
Zheng Xing Xing Ye Ri Bao· 2025-09-02 08:55
Market Overview - The agricultural chemical sector experienced a decline of 2.2% on September 2, with Sierte leading the drop [1] - The Shanghai Composite Index closed at 3858.13, down 0.45%, while the Shenzhen Component Index closed at 12553.84, down 2.14% [1] Stock Performance - Notable gainers in the agricultural chemical sector included: - Yingtai Biological: Closed at 4.62, up 3.59% with a trading volume of 411,100 shares and a turnover of 188 million [1] - New Agricultural Shares: Closed at 19.88, up 3.11% with a trading volume of 111,800 shares and a turnover of 225 million [1] - Taihe Shares: Closed at 32.07, up 2.66% with a trading volume of 98,100 shares and a turnover of 313 million [1] - Major decliners included: - Sierte: Closed at 5.03, down 7.71% with a trading volume of 714,700 shares and a turnover of 361 million [2] - Xin'an Shares: Closed at 10.71, down 5.56% with a trading volume of 636,200 shares and a turnover of 689 million [2] - Lianhua Technology: Closed at 11.33, down 5.19% with a trading volume of 858,800 shares and a turnover of 989 million [2] Capital Flow - The agricultural chemical sector saw a net outflow of 973 million from institutional investors, while retail investors contributed a net inflow of 728 million [2][3] - Key stocks with significant capital flow included: - Xin'an Shares: Institutional net inflow of 31.48 million, retail net outflow of 37.07 million [3] - New Agricultural Shares: Institutional net inflow of 29.05 million, retail net outflow of 19.80 million [3] - Hong Sifang: Institutional net inflow of 24.48 million, retail net outflow of 29.65 million [3]
农化制品板块8月29日涨1.07%,云图控股领涨,主力资金净流出3.55亿元
Zheng Xing Xing Ye Ri Bao· 2025-08-29 08:36
Group 1 - The agricultural chemical sector increased by 1.07% on August 29, with Yuntu Holdings leading the gains [1] - The Shanghai Composite Index closed at 3857.93, up 0.37%, while the Shenzhen Component Index closed at 12696.15, up 0.99% [1] - Key stocks in the agricultural chemical sector showed significant price increases, with Yuntu Holdings rising by 3.88% to a closing price of 11.52 [1] Group 2 - The agricultural chemical sector experienced a net outflow of 355 million yuan from institutional investors, while retail investors saw a net inflow of 361 million yuan [2] - Major stocks like Salt Lake Co. and Baiao Chemical had varying net inflows and outflows from different investor types, indicating mixed investor sentiment [3] - Salt Lake Co. had a net inflow of 98.03 million yuan from institutional investors, while it faced a net outflow of 99.10 million yuan from retail investors [3]
美邦股份2025年中报简析:净利润同比下降23.81%,公司应收账款体量较大
Zheng Quan Zhi Xing· 2025-08-27 22:38
Core Insights - Meibang Co., Ltd. reported a total revenue of 485 million yuan for the first half of 2025, a decrease of 4.76% year-on-year, and a net profit attributable to shareholders of 36.14 million yuan, down 23.81% year-on-year [1] - The company's gross profit margin improved to 32.97%, an increase of 8.67% year-on-year, while the net profit margin decreased to 7.45%, down 20.00% year-on-year [1] - The company has a significant amount of accounts receivable, with accounts receivable accounting for 670.04% of the latest annual net profit [14] Financial Performance - Total revenue for 2024 was 510 million yuan, compared to 485 million yuan in 2025, reflecting a decline of 4.76% [1] - Net profit attributable to shareholders decreased from 47.43 million yuan in 2024 to 36.14 million yuan in 2025, a drop of 23.81% [1] - The gross profit margin increased from 30.34% in 2024 to 32.97% in 2025, while the net profit margin fell from 9.31% to 7.45% [1] - Total expenses (selling, administrative, and financial) amounted to 75.33 million yuan, representing 15.52% of revenue, an increase of 24.59% year-on-year [1] Cash Flow and Assets - Operating cash flow per share was -1.58 yuan, a decrease of 45.52% year-on-year [1] - The company experienced a 37.07% decrease in cash and cash equivalents due to the timing of business annual payment settlements [3] - Accounts receivable increased by 327.72% due to the same timing issue regarding payment settlements [6] Liabilities and Investments - Interest-bearing liabilities rose by 91.58%, from 73.08 million yuan to 140 million yuan, due to new long-term borrowings [11] - The company saw a 39.29% decrease in trading financial assets due to a reduction in maturing financial products [4] - Contract liabilities decreased by 84.73% as a result of reduced advance payments [10] Business Model and Strategy - The company's performance is primarily driven by research and marketing efforts, necessitating a thorough examination of the underlying factors [14] - The historical return on invested capital (ROIC) was 3.05%, indicating weak capital returns, with a median ROIC of 17.26% since its listing [13]
美邦股份:8月25日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-08-26 21:49
2024年1至12月份,美邦股份的营业收入构成为:农药占比99.49%,其他业务占比0.51%。 (记者 胡玲) 每经头条(nbdtoutiao)——能给主人"打电话"的宠物智能手机也来了!宠物产业3000亿元市场大爆 发,行业上市公司"涨"声一片 每经AI快讯,美邦股份(SH 605033,收盘价:25.55元)8月27日发布公告称,公司第三届第八次董事 会会议于2025年8月25日在陕西省西安市未央区草滩三路588号公司三楼会议室召开。会议审议了《关于 公司2025年半年度报告及摘要的议案》等文件。 ...
美邦股份(605033.SH)发布半年度业绩,归母净利润3614万元,同比下降23.81%
智通财经网· 2025-08-26 12:04
Group 1 - The company reported a revenue of 485 million yuan for the first half of 2025, representing a year-on-year decrease of 4.76% [1] - The net profit attributable to the parent company was 36.14 million yuan, down 23.81% year-on-year [1] - The net profit after deducting non-recurring items was 31.65 million yuan, a decline of 15.09% compared to the previous year [1] - The basic earnings per share stood at 0.27 yuan [1]
美邦股份(605033) - 董事会审计委员会工作细则
2025-08-26 09:43
陕西美邦药业集团股份有限公司 陕西美邦药业集团股份有限公司 第一条 为进一步建立健全陕西美邦药业集团股份有限公司(以下简称"公 司")内部控制制度,加强董事会的决策功能,确保董事会对管理层的有效监督, 充分发挥公司内部控制制度的独立性、有效性,完善公司法人治理结构,根据《中 华人民共和国公司法》(以下简称《公司法》)等有关法律、法规、规范性文件 和《陕西美邦药业集团股份有限公司章程》(以下简称《公司章程》)的规定, 公司董事会设立审计委员会,并制定本细则。 第二条 审计委员会是董事会下设的常设专门工作机构,主要负责指导和监 督公司内部审计部门工作、促进公司建立有效的内部控制并提供真实、准确、完 整的财务报告,并监督公司的外部审计、指导内部审计与外部审计机构的沟通、 协调等工作。 第二章 人员组成 第三条 审计委员会由三名董事组成,其中独立董事占多数,审计委员会成 员应当为不在公司担任高级管理人员的董事。 第四条 审计委员会委员由董事长、二分之一以上独立董事或者全体董事的 三分之一以上提名,并由董事会选举产生。 审计委员会主任(召集人)由独立董事中的会计专业人士担任。主任委员由 审计委员会委员过半数选举产生。 ...
美邦股份(605033) - 董事会战略委员会工作细则
2025-08-26 09:43
第二章 人员组成 第三条 战略委员会由三名董事组成,其中应至少包括一名独立董事。 第四条 战略委员会设主任委员一名,由公司董事长担任。 陕西美邦药业集团股份有限公司 陕西美邦药业集团股份有限公司 董事会战略委员会工作细则 第一章 总则 第一条 为适应公司战略发展需要,增强公司核心竞争力,确定公司发展规 划,健全投资决策程序,加强决策科学性,提高重大投资决策的效益和决策的质 量,完善公司治理结构,根据《中华人民共和国公司法》《上市公司治理准则》 等法律、法规、规范性文件以及《陕西美邦药业集团股份有限公司章程》(以下 简称《公司章程》)的有关规定,结合公司的实际情况,公司特设立董事会战略 委员会,并制定本细则。 第二条 董事会战略委员会是董事会按照《公司章程》设立的专门工作机构, 主要负责对公司长期发展战略和重大投资决策进行研究并提出建议。 第五条 战略委员会主任负责召集和主持战略委员会会议,当战略委员会主 任不能或无法履行职责时,由其指定一名其他委员代行其职责;战略委员会主任 既不履行职责,也不指定其他委员代行其职责时,半数以上委员可选举出一名委 员代行战略委员会主任职责,并将有关情况及时向公司董事会报告。 第 ...